TOKYO, Jun 10 (Pulse News Wire) – Cellsource CO.,LTD. (4880.T) reported an interim loss of ¥11 million from its investment fund during the six-month consolidated accounting period ending November 01, 2025 through June 10, 2026.
The company recorded the operating loss based on the final settlement report received from the investment fund. According to the report, the loss stems from the operations of the investment fund.
Regarding the impact on performance, CellSource stated that the effect of this operating loss has been reflected in their recently published mid-term earnings release for the fiscal year ending October 2026.
🟡 Confidence: Standard AI-translated content.